Comparison

SH2D1A Blocking Peptide (C-term)

Item no. ABC-BP19972b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Ameratunga, R., et al. N. Z. Med. J. 122(1304):46-53(2009)
Snow, A.L., et al. J. Clin. Invest. 119(10):2976-2989(2009)
Nagy, N., et al. Proc. Natl. Acad. Sci. U.S.A. 106(29):11966-11971(2009)
Ostrakhovitch, E.A., et al. Cell. Signal. 21(4):540-550(2009)
Schwartzberg, P.L., et al. Nat. Rev. Immunol. 9(1):39-46(2009)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias SH2 domain-containing protein 1A,Duncan disease SH2-protein,Signaling lymphocytic activation molecule-associated protein,SLAM-associated protein,T-cell signal transduction molecule SAP,SH2D1A,DSHP,SAP
Similar products SH2D1A, DSHP, SAP, SH2 domain-containing protein 1A, Duncan disease SH2-protein, Signaling lymphocytic activation molecule-associated protein, T-cell signal transduction molecule SAP, SLAM-associated protein
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 100-114 of HUMAN SH2D1A
Bio Background
This gene encodes a protein that plays a major role in thebidirectional stimulation of T and B cells. This protein containsan SH2 domain and a short tail. It associates with the signalinglymphocyte-activation molecule, thereby acting as an inhibitor ofthis transmembrane protein by blocking the recruitment of theSH2-domain-containing signal-transduction molecule SHP-2 to itsdocking site. This protein can also bind to other related surfacemolecules that are expressed on activated T, B and NK cells, thereby modifying signal transduction pathways in these cells.Mutations in this gene cause lymphoproliferative syndrome X-linkedtype 1 or Duncan disease, a rare immunodeficiency characterized byextreme susceptibility to infection with Epstein-Barr virus, withsymptoms including severe mononucleosis and malignant lymphoma.Multiple transcript variants encoding different isoforms have beenfound for this gene.
Gene Name
SH2D1A
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close